2021 Impact Factor: 1.479
2021 CiteScore: 2.1
Chairman & Editor-in-Chief:
Dariush D. Farhud, MD, Ph.D., MG.
Submitted manuscript, should embrace the following criteria:
Content should not be related to local issues but preferably with critical national or global items.
Types of Manuscripts
These include randomized controlled trials, intervention studies, studies of screening and diagnostic test, outcome studies, and cost-effectiveness analyses. The text of original articles amounting to utmost 3000 words (excluding Abstract, References and Tables) should include Title; the Abstract; Introduction; Materials & Methods; Results; Discussion; Conclusion; Acknowledgement; References, Tables and Figures (Not more than 4500 words).
They should be written by authors considered experts on the subject. Therefore, the corresponding author of the review article must be one of the authors of at least three articles presented in Reference section. Systematic reviews and meta-analysis are more welcomed and they should respectively follow the PRISMA (http://www.prisma-statement.org/) and MOOSE guidelines (http://www.consort-statement.org). Review articles must include an abstract of no more than 250 words, a main text between 2000-3000 words excluding up to 90 references, and up to 6 tables and/or figures (altogether 5500-6000 words).
Short communications are brief reports of research works containing new findings, which are not exceeding 2500 words from introduction through references. The Short Communication consists of Abstract, main body including Introduction, Methods, Results, Discussion, Conclusion; Acknowledgement, References, Tables and Figures (Not more than 3000 words).
Case reports are accepted provided they are of exceptional interest for readers. The case report consists of Abstract (unstructured), Introduction, Case Report, Discussion, Acknowledgements, and References. Case reports must not exceed 1,000 words, 15 references and a reasonable amount of tables and/or figures (Not more than 2500 words).
Letters to the Editor:
Letters could be of two types, commenting either on recently published articles or reporting cases, outbreaks, or original research. The former must be received within 2 months of publication of the article to which they refer and should be no longer than 500 words. The latter should contain no more than 1000 words altogether including up to 10 references and 2 figures and/or tables. They should not be divided into sections.
Guest Editorial is solicited by the Editorial Board. National Reports or similar cases are accepted based on confirmation by Editorial Board.
Submission Preparation Checklist
As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
The manuscript should include Title; No author(s) name; the Abstract; Introduction; Materials & Methods; Results; Discussion; Acknowledgement and References.
The Abstract (no more than 250 words) in structured format as Background, Methods, Results and Conclusion followed by 3 to 5 Keywords must be presented.
Tables in limited numbers should be submitted with the captions placed above. Do not submit tables as photograph. Place explanatory matters in footnotes, not in the heading.
Figures should be in limited numbers, with high quality artwork and mounted on separate pages. The captions should be placed below.
The same data should not be presented in tables, figures and text, simultaneously.
The reference system for our journal is Vancouver. You should write the reference numbers (in parentheses) as they enter the text and arrange them in the Reference section in order to their entrance in the text not alphabetically.
The references should observe the following style:
Article: Jarvis WR, Komshian SV (1995). Epidemiology of nosocomial fungal infections. Clin Infect Dis, 20 (6): 1526-30.
Chapter: Hillyer GV (1998). Immunodiagnosis of human and animal fasciolosis. In: Fasciolosis. Ed, JP Dalton. CABI Publishing, 1st Oxon, Wallingford, UK, pp. 435-48.
Book: Charmaz K (1991). Good days, bad days: The self in chronic illness and time. 2nd ed. New Brunswick: Rutgers University Press. New York.
Monograph on the Internet: Lundstedt S (2003). Analysis of PAHs and their transformation products in contaminated soil and remedial processes. University of Amsterdam, the Netherlands. www.google.com
Thesis: Mohammadi MM. Infant sleep and feeding [PhD thesis]. School of Public Health, Tehran University of Medical Sciences, Iran; 2002.
Note: If the authors have the article prepared using EndNote, we prefer to receive it.
If necessary, please use et al. only after mentioning 3 authors.
Please use only standard abbreviations. Avoid using them in the title and abstract. The full term for which an abbreviation stands should precede its first use in the text unless it is a standard unit of measurement.
Reports of randomized clinical trials should present information on all major study elements, including the protocol, assignment of interventions (methods allocation to treatment groups), and the method of masking (blinding), based on the CONSORT Statement (http://www.consort-statement.org). Iranian articles for this sort should be registered first via (www.irct.ir/) because no RCT articles are accepted unless it contains the official registered code. Registration in the following trial registers is acceptable as well: http://www.actr.org.au/
Authorship credit should be based only on substantial contributions to each of the three components mentioned below:
Participation solely in the acquisition of funding or the collection of data does not justify authorship. General supervision of the research group is not sufficient contributor should have participated sufficiently in the work to take public responsibility for appropriate portions of the content of the manuscript.
No reprints are presented to authors. The Journal is open access and all authors may acquire their article full text free of charge through the web.
The relevant Ethics committee/ institution review boards of the respective institutions must approve the study. The study itself should follow the ethical standards of the Helsinki Declaration, as revised in 2013 (available at http://www.wma.net/en/30publications/10policies/b3/).
Ensure confidentiality of subjects by desisting from mentioning participants’ names, initials or hospital numbers, especially reporting experiments on animals, indicate whether the institution’s or a national research council’s guide for, or any national law on the care and use Evidence for approval by a local Ethics Committee (for both human as well as animal studies) must be supplied by the authors on demand. IJPH will not consider any paper, which is ethically unacceptable. The related items should be inserted under the ‘Materials and Methods’ section.
Protection of Patients' Rights to Privacy
Informed consent from the participants and from the parents or legal guardians of minors should be taken and stated in the study under the ‘Materials and Methods’ section.
Authors should remove patients' names from figures. Any data leading to direct recognize of the patient, strictly should be omitted.
IJPH is a member of COPE and follows its Best Practice Guidelines for Journal Editors. Plagiarism of text from a previously published manuscript by the same or another author is a serious publication offence. Small amounts of text may be used, but only where the source of the material quoted is clearly acknowledged and the text is inserted in quotation mark. If there is an allegation of plagiarism, scientific misconduct or fraud, IJPH will follow the recommendations of the COPE and ICMJE. The Journal reserves the right to report the allegations to the author’s institution or any other agency.
Conflicts of interest
Submitting a manuscript must be accompanied with a statement from the authors disclosing financial and personnel relationship that might bias their work, if any. Besides, they are requested to evident whether impending conflicts do or do not exist. A separate page should cover this proclamation and if there are further details, could be mentioned in covering letter. If an organization encompasses any financial interest in the outcome of the study, the authors are appealed to provide a declaration that have full access to all the data in the study and take complete responsibility for the integrity of the data and the accuracy of the data analysis.
IJPH is a peer-reviewed journal. All manuscripts will be acknowledged upon presenting to the Journal office, if all stated requirements are met. According to the policy of peer review in our Journal, a large extent of manuscripts are rejected through an in-house evaluation process based on a category of criteria including over flow of manuscripts, out of scope cases, poor outcome, local studies, clinical contents etc. This process takes no more than two weeks and the author(s) will be informed of the primary decision. The first stage passed manuscripts are sent to two or three reviewers. The whole review process depends on receiving referees' comments and revising the manuscripts based on these comments to the author. On receipt of the revised article from the author, and after final approving by referees, the letter of acceptance is issued to the corresponding author only. Due to plenty of papers waiting for publishing, the article takes more than one year for publication. Authors have the right to communicate to the editor if they do not wish their manuscript to be reviewed by a particular reviewer because of potential conflicts of interest. The author can also suggest the name of possible competent reviewers but it is up to the editor to accept it. No article is rejected unless negative comments are received from at least two reviewers.
To assist the speed of peer review process, authors are requested to introduce four well-known experts with their contact details, but the Editor-in-Chief would be emancipated finally.
The revised version of the manuscript should be included with reply to referees’ comments separately article to article. In addition, the changes should be marked as underlined or colored text in the article.
Authors are sent galley proofs for checking the production after acceptance of the article. Proofs are sent by e-mail as Word files and considering that the Journal is published monthly, if for any reason, after 2 days, the Journal does not receive any reply, we consider the manuscript approved, and no changes will be acceptable after that. It is the authors’ responsibility to check that all the text and data as contained in the page proofs are correct and suitable for publication. We request that authors pay particular attention to author's names and affiliations, as it is essential that these details are accurate when the article is published. In this step, the authors absolutely, cannot add any authors or large sentences to the article, besides; they are not allowed to change the corresponding author.
After approving the galley proof, no changes would be accepted and the responsibility would be on author(s) side.
Iranian Journal of Public Health allow the author(s) to hold the copyright without restrictions. Also the journal allow the author(s) to retain publishing rights without restrictions.
Dear corresponding authors
According to policy imposed by the Journal administration from 10 Nov 2015, corresponding author(s) are requested to pay the publication charge.
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.
The Editorial Board of the journal, reserves the right to accept or reject the article in any stage and any time or delete a part of the text, tables or figures, if necessary.
|All the work in this journal are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.|